Emcure Pharma Establishes Emcutix Biopharma for Dermatology
28 Oct 2024 //
#N/A
New Study Shows SL-NAD+ Effectively Delivers NAD+ Into Cells
01 Sep 2024 //
PR NEWSWIRE
iX Biopharma Signs Exclusive License Agreement For Wafermine
29 Nov 2021 //
PRNEWSWIRE
Seelos Acquires Exc. License of iX Biopharma`s Wafer-Based Delivery Platform
24 Nov 2021 //
PRNEWSWIRE
iX Biopharma receives positive EMA Scientific Advice for Wafermine™
08 Dec 2020 //
PRNEWSWIRE
iX Biopharma`s Xativa(TM) bags "CBD Product of the Year" accolade
08 Dec 2020 //
PRNEWSWIRE